Answers are grounded in this paper and cite their sources.
High-dose trivalent compared with standard-dose quadrivalent influenza vaccine did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations in patients with high-risk cardiovascular disease in the INVESTED trial. Whether humoral immune response to influenza vaccine is associated with clinical outcomes is unknown.
No takes yet. Share an insight, caveat, or question.
Peikert et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: